CAM
Cozad Asset Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,616
| Closed | -$242K | – | 410 |
|
|
2024
Q2 | $242K | Hold |
2,616
| – | – | 0.02% | 351 |
|
|
2024
Q1 | $250K | Buy |
+2,616
| New | +$250K | 0.03% | 349 |
|
|
2023
Q3 | – | Sell |
-2,616
| Closed | -$247K | – | 386 |
|
|
2023
Q2 | $247K | Hold |
2,616
| – | – | 0.03% | 338 |
|
|
2023
Q1 | $216K | Buy |
+2,616
| New | +$216K | 0.03% | 345 |
|
|
2022
Q4 | – | Sell |
-2,616
| Closed | -$216K | – | 378 |
|
|
2022
Q3 | $216K | Sell |
2,616
-300
| -10% | -$24.8K | 0.04% | 323 |
|
|
2022
Q2 | $277K | Sell |
2,916
-435
| -13% | -$41.3K | 0.04% | 295 |
|
|
2022
Q1 | $394K | Sell |
3,351
-3,122
| -48% | -$367K | 0.06% | 257 |
|
|
2021
Q4 | $839K | Sell |
6,473
-1,034
| -14% | -$134K | 0.12% | 172 |
|
|
2021
Q3 | $850K | Sell |
7,507
-10,239
| -58% | -$1.16M | 0.13% | 167 |
|
|
2021
Q2 | $1.84M | Sell |
17,746
-16,495
| -48% | -$1.71M | 0.29% | 92 |
|
|
2021
Q1 | $2.86M | Sell |
34,241
-10
| -0% | -$836 | 0.47% | 56 |
|
|
2020
Q4 | $3.13M | Sell |
34,251
-940
| -3% | -$85.8K | 0.56% | 46 |
|
|
2020
Q3 | $2.81M | Sell |
35,191
-3,015
| -8% | -$241K | 0.53% | 51 |
|
|
2020
Q2 | $2.64M | Buy |
38,206
+24,569
| +180% | +$1.7M | 0.54% | 51 |
|
|
2020
Q1 | $2.57M | Buy |
13,637
+667
| +5% | +$126K | 0.89% | 31 |
|
|
2019
Q4 | $3.03M | Buy |
12,970
+2,350
| +22% | +$548K | 0.81% | 32 |
|
|
2019
Q3 | $2.34M | Buy |
+10,620
| New | +$2.34M | 0.67% | 45 |
|